RCUS Latest News

Arcus Biosciences (NYSE:RCUS) Trading Up 5.4% Following Analyst Upgrade

defenseworld.net — Apr 3, 2026

Arcus Biosciences, Inc. (NYSE: RCUS - Get Free Report) shares were up 5.

5 Biotechs That Big Pharma Could Snap Up as Oncology M&A Heats Up

247wallst.com — Apr 1, 2026

Oncology M&A activity is accelerating as large pharmaceutical companies race to replenish pipelines facing patent cliffs and seek exposure to next-gen

Arcus Biosciences Announces New Employment Inducement Grants

businesswire.com — Mar 24, 2026

HAYWARD, Calif. --(BUSINESS WIRE)--Arcus Biosciences, Inc.

Arcus Biosciences Announces New Employment Inducement Grants

businesswire.com — Mar 9, 2026

HAYWARD, Calif. --(BUSINESS WIRE)--Arcus Biosciences, Inc.

Arcus Biosciences: Q4 Beat And Casdatifan's Story So Far

seekingalpha.com — Mar 3, 2026

Arcus Biosciences posted strong FY25 results, beating EPS and revenue estimates despite no commercial products and heavy R&D investment. RCUS's valua